Invitation to Revenio Group Corporation’s audiocast and teleconference
Revenio Group Corporation’s Q3 financial report will be published on Thursday, 21 October 2021, approximately at 9:00 am.
An audiocast and teleconference for analytics and investors is held in English at 3:00 pm on the same day.
Link to the event: https://revenio.videosync.fi/2021-q3-results
FI: +358 981710310
SE: +46 856642651
UK: +44 3333000804
US: +1 6319131422
For further information, please contact:
Robin Pulkkinen, CFO, tel. +358 50 505 9932
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. In addition, the Group’s eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities.
In 2020, the Group’s net sales totaled EUR 61.1 million and its operating profit amounted to EUR 17.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.